The diltiazem different doses study - A dose-response study of once-daily diltiazem therapy for hypertension

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 4, 1996, Pages 469-475

  Nilsson, Peter ^a   Lindholm, Lars H ^a   Hedner, Thomas ^b  

^a LUND UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood pressure; Diltiazem; Heart rate

Indexed keywords

DILTIAZEM; PLACEBO;

ADULT; ANKLE EDEMA; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERANCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WELLBEING;

ADULT; AGED; BLOOD PRESSURE; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLACEBOS;

EID: 0029960785     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199604000-00003     Document Type: Article

References (26)

1. Chaffman M, Brogden RN. Diltiazem - a review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29:387-454.
2. Buckley MM-T, Grant SM, Goa KL, McTavish D, Sorkin EM. Diltiazem - a reappraisal of its pharmacological properties and therapeutic use. Drugs 1990;39:757-806.
3. Yorifugi S, Kawai Y, Arami S, et al. Hypotensive effect of diltiazem hydrochloride (Herbesser tablets) in patients with essential hypertension. J Adult Dis 1979;9:893-907.
4. Ikeda M, Aoki K, Arakawa T, et al. Clinical effect of diltiazem (Herbesser) on essential hypertension; comparison with placebo by double-blind method. Med Prog 1979;110:302.
5. Watanabe T, Yamazaki N, Ogawa K, et al. Clinical effect of diltiazem (Herbesser) on essential hypertension: double-blind group comparison between diltiazem and reserpine. Med Prog 1982;120:854-71.
6. McGraw BF, Walker SD, Hemberger JA, et al. Clinical experience with diltiazem in Japan. Pharmacotherapy 1982;2: 156-61.
7. Aoki K, Sata K, Kondo S, Yamamoto M. Hypotensive effects of diltiazem to normals and essential hypertensives. Eur J Clin Pharmacol 1983;25:475-80.
8. Yamakado T, Oonishi N, Kondo S, Noziri A, Nakano T, Takezawa H. Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol. Am J Cardiol 1983;52:1023-7.
9. Sawai K. Effects of long-term administration of diltiazem hydrochloride in hypertensive patients. Clin Ther 1983;5: 422-35.
10. Maeda K, Takasugi T, Tuskano Y, et al. Clinical study of the hypotensive effect of diltiazem hydrochloride. Int J Clin Pharmacol Ther Toxicol 1981;19:47-55.
11. Klein W, Brandt D, Vrecko K, Haerringer M. Role of calcium antagonists in the treatment of essential hypertension. Circ Res 1983:52(suppl):I-174-98.
12. Safar ME, Simon AC, Levenson JA, Cazor JL. Hemodynamic effects of diltiazem in hypertension. Circ Res 1983;52 (suppl):I-169-73.
13. Trimarco B, DeLuca N, Ricciardelli B, et al. Diltiazem in the treatment of mild to moderate essential hypertension. Comparison with metoprolol in a crossover, double-blind trial. J Clin Pharmacol 1984;24:218-27.
14. Klein W. Treatment of hypertension with calcium channel blockers: European data. Am J Med 1984;77:143-6.
15. Inouye I, Massie B, Benowitz N, et al. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide. Am J Cardiol 1984;53:1588-92.
16. Lewis JE. Diltiazem in hypertension: a preliminary dose-finding and efficacy multicenter study. Curr Ther Res 1985; 37:566-79.
17. Frishman WH, Charlap S, Goldberger J, et al. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension. Am J Cardiol 1985;56:41H-6H.
18. Andrén L, Höglund P, Dotevall A, et al. Diltiazem in hypertensive patients with type 11 diabetes mellitus. Am J Cardiol 1988;62:114G-20G.
19. Nikkilä M, Inkovaara J, Heikkinen J, Olsson S-O. Antihypertensive effects of diltiazem in a slow release formulation in patients with mild to moderate essential hypertension. Am J Cardiol 1989;63:1227-30.
20. Thulin T, Hedner T, Gustavsson S, Olsson SO. Diltiazem compared with metoprolol as add on therapy to diuretics in hypertension. J Hum Hypertens 1991;5:107-14.
21. Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989;7:551-9.
22. Platou E, Osmundsen K, Gendersen R, et al. A randomized double-blind multicenter long-term comparison of diltiazem and nifedipine in patients with essential hypertension [Abstract]. Proceedings of XI Congress of the European Society of Cardiology, Nice. Eur Heart J 1989;10 (suppl.):P1538.
23. Lund-Johansen P, Omvik P. Effect of long-term diltiazem treatment on central haemodynamics and exercise endurance in essential hypertension. Eur Heart J 1990;11:543-51.
24. Lacourcière Y, Poirier L, Lefebvre J, Burford RG. Clinical efficacy of forced titrated doses of diltiazem extended-release. A placebo controlled study. Am J Hypertens 1995; 8:282-6.
25. Nilsson P, Lindholm LH, Scherstén B. No additional beneficial effects in hypertensives well cared for when their medication is changed to diltiazem - a one-year, randomized pilot study. High Blood Pressure Cardiovasc Prev 1994;3:57-63.
26. The NORDIL group. The Nordic Diltiazem Study (NORDIL). A prospective intervention trial of calcium antagonist therapy in hypertension. Blood Pressure 1993;2:312-21.